Development Level

Tbio 56 | 11,445
Tchem 10 | 1,598
Tdark 9 | 6,588
Tclin 3 | 613

IMPC Phenotype

preweaning lethality, complete... 5 | 979
abnormal head morphology 3 | 10
decreased body weight 3 | 161
decreased total body fat amoun... 3 | 207
male infertility 3 | 123
abnormal cranium morphology 2 | 36
decreased bone mineral content 2 | 151
decreased circulating calcium ... 2 | 36
decreased circulating choleste... 2 | 93
decreased circulating serum al... 2 | 82
decreased circulating total pr... 2 | 49
decreased lean body mass 2 | 135
embryonic lethality prior to t... 2 | 278
preweaning lethality, incomple... 2 | 499
abnormal behavior 1 | 298
abnormal external female genit... 1 | 1
abnormal external male genital... 1 | 1
abnormal femur morphology 1 | 14
abnormal humerus morphology 1 | 11
abnormal joint morphology 1 | 23
abnormal kidney morphology 1 | 65
abnormal lens morphology 1 | 81
abnormal locomotor behavior 1 | 24
abnormal retinal blood vessel ... 1 | 26
abnormal retinal vasculature m... 1 | 27
abnormal snout morphology 1 | 23
abnormal spleen morphology 1 | 55
abnormal tail morphology 1 | 25
abnormal tail movements 1 | 12
abnormal tibia morphology 1 | 14
abnormal ulna morphology 1 | 8
abnormal vertebrae morphology 1 | 18
cardiovascular system phenotyp... 1 | 36
cataract 1 | 92
decreased body length 1 | 101
decreased caudal vertebrae num... 1 | 53
decreased circulating HDL chol... 1 | 68
decreased circulating LDL chol... 1 | 38
decreased circulating fructosa... 1 | 30
decreased circulating sodium l... 1 | 22
decreased leukocyte cell numbe... 1 | 73
embryonic lethality prior to o... 1 | 239
enlarged lymph nodes 1 | 37
hypoactivity 1 | 132
increased circulating creatini... 1 | 38
increased circulating fructosa... 1 | 13
increased grip strength 1 | 41
increased mean corpuscular hem... 1 | 96
increased mean corpuscular vol... 1 | 92
prolonged QT interval 1 | 38
prolonged ST segment 1 | 36
vertebral fusion 1 | 23

Disease

Carcinoma 56 | 11,493
ovarian cancer 54 | 8,520
osteosarcoma 42 | 7,950
group 3 medulloblastoma 35 | 4,104
atypical teratoid / rhabdoid tumor 32 | 5,112
psoriasis 32 | 6,694
medulloblastoma, large-cell 30 | 6,241
ependymoma 27 | 4,679
glioblastoma 25 | 5,792
lung cancer 25 | 4,740
Kidney cancer 24 | 2,613
malignant mesothelioma 24 | 3,232
primitive neuroectodermal tumor 22 | 3,035
oligodendroglioma 21 | 2,850
Breast cancer 20 | 3,578
intraductal papillary-mucinous neoplasm (IPMN) 19 | 3,291
Intellectual disability 18 | 1,016
Pick disease 17 | 1,894
adult high grade glioma 17 | 3,801
Microcephaly 15 | 166
colon cancer 15 | 1,478
intraductal papillary-mucinous carcinoma (IPMC) 15 | 2,989
non-small cell lung cancer 15 | 2,890
Cognitive delay 14 | 608
Global developmental delay 14 | 608
Mental and motor retardation 14 | 608
Astrocytoma, Pilocytic 13 | 3,081
astrocytic glioma 13 | 2,597
Multiple myeloma 12 | 1,332
Short stature 12 | 531
Autosomal recessive predisposition 11 | 1,442
Dull intelligence 11 | 645
Low intelligence 11 | 645
Mental Retardation 11 | 645
Mental deficiency 11 | 645
Poor school performance 11 | 645
Small head 11 | 374
lung adenocarcinoma 11 | 2,716
nasopharyngeal carcinoma 11 | 1,058
intraductal papillary-mucinous adenoma (IPMA) 10 | 2,955
Cancer 9 | 2,499
Epilepsy 9 | 792
Schizophrenia 9 | 1,160
Seizures 9 | 596
breast carcinoma 9 | 1,638
invasive ductal carcinoma 9 | 2,951
pancreatic cancer 9 | 2,398
pancreatic ductal adenocarcinoma liver metastasis 9 | 1,962
subependymal giant cell astrocytoma 9 | 2,287
tuberculosis 9 | 2,010
Downward slant of palpebral fissure 8 | 158
Joubert syndrome 8 | 66
astrocytoma 8 | 1,146
diabetes mellitus 8 | 1,728
ulcerative colitis 8 | 1,819
Waldenstrons macroglobulinemia 7 | 765
juvenile dermatomyositis 7 | 1,187
tuberculosis and treatment for 6 months 7 | 409
Anteverted nostril 6 | 191
Dilated ventricles (finding) 6 | 121
Glaucoma 6 | 239
Muscle hypotonia 6 | 571
Obesity 6 | 678
Pachygyria 6 | 41
Seckel syndrome 6 | 34
Sloping forehead 6 | 46
adrenocortical carcinoma 6 | 1,428
dermatomyositis 6 | 966
ductal carcinoma in situ 6 | 1,745
non primary Sjogren syndrome sicca 6 | 891
progressive supranuclear palsy 6 | 676
Abnormality of retinal pigmentation 5 | 111
Agenesis of corpus callosum 5 | 83
Cataract 5 | 297
Fetal Growth Retardation 5 | 189
Hypertensive disease 5 | 292
Increase in blood pressure 5 | 119
Infant, Small for Gestational Age 5 | 176
Intrauterine retardation 5 | 176
Lens Opacities 5 | 231
Lissencephaly 5 | 69
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1 5 | 16
Microcephalic osteodysplastic primordial dwarfism type II 5 | 13
Nephronophthisis 5 | 80
Nystagmus 5 | 317
Prenatal onset 5 | 139
Retinal pigment epithelial abnormality 5 | 111
Severe mental retardation (I.Q. 20-34) 5 | 99
acute myeloid leukemia 5 | 783
group 4 medulloblastoma 5 | 1,855
pediatric high grade glioma 5 | 1,064
pituitary cancer 5 | 1,972
posterior fossa group B ependymoma 5 | 416
Bipolar Disorder 4 | 666
Duchenne muscular dystrophy 4 | 601
Endometriosis 4 | 540
Hypoplastic mandible condyle 4 | 275
Rheumatoid arthritis 4 | 1,191
acute quadriplegic myopathy 4 | 1,158
interstitial cystitis 4 | 2,312

Tissue

Blood and immune system 78 | 16,909
Cardiovascular System 78 | 15,192
Digestive Tract 78 | 17,369
Endocrine System 78 | 18,159
Female tissues 78 | 17,400
Liver and Pancreas 78 | 16,750
Male tissues 78 | 17,142
Nervous System 78 | 16,725
Respiratory system 78 | 16,393
Skin and soft tissues 78 | 17,230
Urinary Tract 78 | 16,678

Target Family

Non-IDG 67 | 12,091
Kinase 7 | 634
Enzyme 4 | 4,145

Reactome Pathway

Recruitment of NuMA to mitotic... 78 | 78
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Tubulin beta-4A chain TUBB4A Tclin Non-IDG -2.98371 896.1 90
Nuclear mitotic apparatus protein 1 NUMA1 Tbio Non-IDG -2.76544 575.8 235
Nuclear distribution protein nudE homolog 1 NDE1 Tbio Non-IDG -2.01711 96.0 192
Centrosomal protein of 57 kDa CEP57 Tbio Non-IDG -0.98216 11.8 177
HAUS augmin-like complex subunit 2 HAUS2 Tbio Non-IDG 0.71 0.12 44
Centromere protein J CENPJ Tbio Non-IDG -1.79588 59.0 102
Centrosomal protein of 131 kDa CEP131 Tbio Non-IDG -1.78486 61.9 82
Centrosomal protein of 41 kDa CEP41 Tdark Non-IDG -0.41185 3.40 46
HAUS augmin-like complex subunit 5 HAUS5 Tbio Non-IDG 0.34 0.65 77
CDK5 regulatory subunit-associated protein 2 CDK5RAP2 Tbio Non-IDG -1.70804 54.4 81